MENA, Medical & Clinical Emerging Markets, GSK, Istanbul, Turkey.
Global Medical Affairs Rota/MMRV, GSK, Wavre, Belgium.
Hum Vaccin Immunother. 2019;15(11):2754-2768. doi: 10.1080/21645515.2019.1603984. Epub 2019 May 17.
Rotavirus gastroenteritis imposes a heavy burden on low- and middle-income countries. The World Health Organization defines the Eastern Mediterranean region (WHO-EMRO) as a diverse area in terms of socioeconomic status and health indicators. Rotavirus vaccination has been introduced, at least partially, in 19 out of the 22 EM countries; however, vaccine coverage remains low, and data on rotavirus disease burden is scarce.Available data on rotavirus prevalence, seasonality, vaccination status, and genotype evolution was systematically compiled following a literature review that identified 165 relevant WHO-EMRO epidemiology studies published between 1990 and 2017.Although the infectious agents responsible for acute gastroenteritis vary over time, rotavirus remained the leading cause of acute gastroenteritis in children, as seen in 76.3% of reviewed publications. Younger children (<2 years old) were at higher risk and thus increased vaccination coverage and surveillance systems are required to reduce the rotavirus gastroenteritis burden in WHO-EMRO countries.
轮状病毒胃肠炎给中低收入国家带来了沉重的负担。世界卫生组织(世卫组织)将东地中海区域(世卫组织东地中海区域)定义为在社会经济地位和卫生指标方面具有多样性的地区。22 个东地中海国家中至少有 19 个国家部分引入了轮状病毒疫苗接种;然而,疫苗接种覆盖率仍然很低,而且关于轮状病毒疾病负担的数据也很有限。通过文献综述,系统地收集了有关轮状病毒流行率、季节性、疫苗接种状况和基因型演变的现有数据,文献综述确定了 1990 年至 2017 年期间发表的 165 篇与世卫组织东地中海区域相关的流行病学研究。虽然导致急性胃肠炎的感染因子随时间而变化,但轮状病毒仍然是儿童急性胃肠炎的主要原因,在审查的出版物中有 76.3%的情况如此。年龄较小的儿童(<2 岁)风险更高,因此需要增加疫苗接种覆盖率和监测系统,以减轻世卫组织东地中海区域国家的轮状病毒胃肠炎负担。